Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence. from 2016‐2019 and secondary diagnosis of T2DM. from 2016‐2019 and secondary diagnosis of T2DM. Of those patients, 35.43% (n=273,993) were diabetic and 64.57% (n=151,112) were non‐diabetic.

Diabetes 40

Diabetes Coronary Artery Disease Atrial Fibrillation Dementia 40

Circulation: Heart Failure

MARCH 8, 2024

Between 2016 and 2018, 3285 MESA participants from 6 field centers underwent comprehensive speckle-tracking echocardiography with passive leg raise maneuver, Kansas City Cardiomyopathy Questionnaire, 6-minute walk test, arterial stiffness assessment, and proteomics (including NT-proBNP [N-terminal pro-B-type natriuretic peptide]).Results:Median

Heart Failure 40

Heart Failure Atherosclerosis Risk Factors Kidney Disease 40

Stroke Journal

FEBRUARY 1, 2024

Patients with atrial fibrillation had a higher risk of AIS (1.47, 1.18 - 1.84) and MACE (1.26, 1.07 - 1.49). Results:Among 10,652 ICH patients (median age [IQR]: 70 [58 - 80] years; 47.7% female; 43.2% lobar ICH), 3.3%, 3.1%, 0.5%, and 8.1%, respectively, experienced r-ICH, AIS, AMI, and MACE.

Hemorrhage 40

Hemorrhage Myocardial Infarction Atrial Fibrillation Medicare 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

The National Inpatient Sample (NIS) database from 2016‐2019 for patients with a principal diagnosis of AIS using the ICD‐10 code I63 was queried. Outcome measures studied included prolonged length of stay (LOS), discharge disposition, and inpatient mortality.ResultsWe identified 2,939,160 patients with AIS between 2016 and 2019.

Heart Failure 40

Heart Failure Cardiomyopathy Inpatient Stroke 40

Dr. Paddy Barrett

AUGUST 15, 2023

Just for clarity, type 2 diabetes is when insulin resistance progresses to the point that your body can no longer keep your blood glucose levels under control. So if you have type 2 diabetes, you, by definition, are insulin resistant. For each additional feature, the likelihood and likely severity of insulin resistance increases.

Blood Pressure 52

Blood Pressure Risk Factors Diabetes Cholesterol 52

Journal of the American Heart Association

JANUARY 23, 2024

BackgroundMeta‐analyses of large clinical trials investigating SGLT2 (sodium‐glucose cotransporter‐2) inhibitors have suggested their protective effects against atrial fibrillation in patients with type 2 diabetes. An active‐comparator, new‐user design was used, and the 2 groups of patients were matched using propensity scores.

Atrial Fibrillation 75

Atrial Fibrillation Diabetes Risk Factors Cardiovascular Disease 75

Stroke Journal

FEBRUARY 1, 2024

0.90], P<0.001), history of atrial fibrillation (OR, 1.27 [95% CI, 1.01-1.60], 1.60], P<0.001), and absence of diabetes (OR, 0.77 [95% CI, 0.60-0.98], Patient and hospital-level characteristics associated with use and outcome of reperfusion therapies were analyzed. 0.98], P<0.001).Conclusions:In

Stroke 40

Stroke Strokes Outcomes Atrial Fibrillation 40